Extra-pair copulation (EPC), i. e. copulation between one individual and another of the opposite sex that is not its social partner, a pre-requisite for EPP, can be frequent in breeding colonies [ 9- 11].
Conversely, physicians who provided long-term follow-up care for EPC (i,e., neonatal physicians and paediatric neurologists) indicated that considering HRQoL was essential, at the same time to improve the relation of care and the information.
In contrast, HSCs (assessed by flow cytometry) were not associated with CVE and patient survival in the follow-up, highlighting the potential role of EPCs, i.e. cells that are committed to the endothelial lineage, in vascular repair and CV morbidity in CKD patients.
Finally, a comparison between existing EPC values (i.e. for the nuclear industry) and m-EPCs is also provided to clarify industrial safety perspectives.
To explore the impact of the discrepancies I have identified on the key regression of mutation rate against EPC rate, I attempted to repeat exactly the regression performed in the original paper.
EPC Variant I and EPC Variant II represent two extreme cases: EPC Variant II adjusts the frame size at the very beginning of a frame if idle or colliding transmissions, other than successful transmissions, happen at the first time slot, while EPC Variant I adjusts the frame size for the next layer when all the transmission contentions in the current layer are finished.
For example, when N>250 and x EPC=64, the transmission efficiency of EPC Variant I is below 0.2 for the constant Δ, which is even worse than that of the static framed Aloha with a proper frame size.
Fluorescently dye-tagged EPCs were administered i.v. into mice receiving simultaneous intragraft injections of RA SF that was either "sham" immunoneutralized with non-specific IgG or immunoneutralized with specific antibody to human Id1.
Once grafts took, 2.5 × 10 fluorescently dye-tagged (PKH26 dye, Sigma-Aldrich, St . Louis MO, USA) EPCs were injected i.v. into mice while they were receiving simultaneous intragraft injections of RA SF (100 μl) that was either "sham" immunoneutralized with non-specific IgG or immunoneutralized with the specific antibody to human Id1.
There was no significant difference in the numbers of blood vessels per region of interest (ROI) between the two groups (6.25 ± 2.56 blood vessels/ROI in EV EPC vs. 4.66 ± 1.46 blood vessels/ROI in GBP-1 EPC).
They quantitatively evaluated the expression of EPCs and endothelial markers (i.e., CD133 and VE-cadherin) before the experiment and after the injection.
